Scott Rottinghaus
Chief Tech/Sci/R&D Officer en ENANTA PHARMACEUTICALS, INC. .
Fortuna: 493 891 $ al 31/03/2024
Perfil
Scott T.
Rottinghaus is currently the Chief Medical Officer & Senior Vice President at Enanta Pharmaceuticals, Inc. Previously, he worked as the Vice President & Head-Clinical Development at Alexion Pharmaceuticals, Inc. He received his doctorate from Mayo Medical School, his graduate degree from the University of Cambridge, and his undergraduate degree from Kansas State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/02/2024 | 28 287 ( 0.13% ) | 493 891 $ | 31/03/2024 |
Cargos activos de Scott Rottinghaus
| Empresas | Cargo | Inicio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 08/08/2022 |
Antiguos cargos conocidos de Scott Rottinghaus.
| Empresas | Cargo | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Scott Rottinghaus.
| University of Cambridge | Graduate Degree |
| Kansas State University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Rottinghaus
